Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,033 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels.
Shapiro AD, Ragni MV, Kulkarni R, Oldenberg J, Srivastava A, Quon DV, Pasi KJ, Hanabusa H, Pabinger I, Mahlangu J, Fogarty P, Lillicrap D, Kulke S, Potts J, Neelakantan S, Nestorov I, Li S, Dumont JA, Jiang H, Brennan A, Pierce GF. Shapiro AD, et al. Among authors: srivastava a. J Thromb Haemost. 2014 Nov;12(11):1788-800. doi: 10.1111/jth.12723. Epub 2014 Oct 10. J Thromb Haemost. 2014. PMID: 25196897 Free article. Clinical Trial.
Laboratory issues in bleeding disorders.
Lillicrap D, Nair SC, Srivastava A, Rodeghiero F, Pabinger I, Federici AB. Lillicrap D, et al. Among authors: srivastava a. Haemophilia. 2006 Jul;12 Suppl 3:68-75. doi: 10.1111/j.1365-2516.2006.01279.x. Haemophilia. 2006. PMID: 16683999 Review.
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.
Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Ingerslev J, Lee CA, Lillicrap D, Mannucci PM, Mazurier C, Meyer D, Nichols WL, Nishino M, Peake IR, Rodeghiero F, Schneppenheim R, Ruggeri ZM, Srivastava A, Montgomery RR, Federici AB; Working Party on von Willebrand Disease Classification. Sadler JE, et al. Among authors: srivastava a. J Thromb Haemost. 2006 Oct;4(10):2103-14. doi: 10.1111/j.1538-7836.2006.02146.x. Epub 2006 Aug 2. J Thromb Haemost. 2006. PMID: 16889557 Free article. Review.
Emerging therapies for haemophilia - Global perspective.
Mahlangu J, Cerquiera M, Srivastava A. Mahlangu J, et al. Among authors: srivastava a. Haemophilia. 2018 May;24 Suppl 6:15-21. doi: 10.1111/hae.13510. Haemophilia. 2018. PMID: 29878661 Review.
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.
Castaman G, Rodeghiero F, Tosetto A, Cappelletti A, Baudo F, Eikenboom JC, Federici AB, Lethagen S, Linari S, Lusher J, Nishino M, Petrini P, Srivastava A, Ungerstedt JS. Castaman G, et al. Among authors: srivastava a. J Thromb Haemost. 2006 Oct;4(10):2164-9. doi: 10.1111/j.1538-7836.2006.02070.x. J Thromb Haemost. 2006. PMID: 16999850 Free article.
Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency.
Ross C, Rangarajan S, Karimi M, Toogeh G, Apte S, Lissitchkov T, Acharya S, Manco-Johnson MJ, Srivastava A, Brand B, Schwartz BA, Knaub S, Peyvandi F. Ross C, et al. Among authors: srivastava a. J Thromb Haemost. 2018 Feb;16(2):253-261. doi: 10.1111/jth.13923. Epub 2018 Jan 22. J Thromb Haemost. 2018. PMID: 29220876 Free article. Clinical Trial.
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.
Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A. Rodeghiero F, et al. Among authors: srivastava a. J Thromb Haemost. 2005 Dec;3(12):2619-26. doi: 10.1111/j.1538-7836.2005.01663.x. J Thromb Haemost. 2005. PMID: 16359502 Free article.
Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity.
Peyvandi F, Di Michele D, Bolton-Maggs PH, Lee CA, Tripodi A, Srivastava A; Project on Consensus Definitions in Rare Bleeeding Disorders of the Factor VIII/Factor IX Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Peyvandi F, et al. Among authors: srivastava a. J Thromb Haemost. 2012 Sep;10(9):1938-43. doi: 10.1111/j.1538-7836.2012.04844.x. J Thromb Haemost. 2012. PMID: 22943259 Free article. No abstract available.
7,033 results